Ann: Participation in Upcoming U.S. Investor Conferences, page-5

Biotech can be slow moving and finally erupting massively on good news.
When investing in this field one should be aware of it, long lead up times but very high upside.

Listen to your adviser might be a good idea, he seems to understand this properly.


All indicators with US based offices in San Diego, new board members, positive news in both ocular programs, excellent first data from neuro degenerative side of things, point to material developments.
The very strong biotech bank and investor activity this year tells the story.

Patience in these stocks can be wealth creating if one is prepared for the milestones.
There are plenty of announcements to look forward to in the next months.

all IMO